NanoViricides (NYSEAMERICAN:NNVC) last issued its quarterly earnings data on Tuesday, November 14th. The company reported ($0.03) EPS for the quarter.
NanoViricides (NNVC) opened at $0.91 on Monday. The company has a market capitalization of $57.63, a PE ratio of -6.07 and a beta of 0.20. NanoViricides has a one year low of $0.83 and a one year high of $1.64.
TRADEMARK VIOLATION NOTICE: This article was posted by American Banking News and is the property of of American Banking News. If you are accessing this article on another domain, it was stolen and reposted in violation of US & international trademark and copyright laws. The correct version of this article can be viewed at https://www.americanbankingnews.com/2018/02/05/nanoviricides-nnvc-to-release-earnings-on-monday.html.
NanoViricides Company Profile
NanoViricides, Inc is a nano-biopharmaceutical company. The Company is a development-stage company with several drugs in various stages of development. The Company focuses on its research and clinical programs on specific anti-viral therapeutics. The Company is engaged in the application of nanomedicine technologies to the issues of viral diseases.
Receive News & Ratings for NanoViricides Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoViricides and related companies with MarketBeat.com's FREE daily email newsletter.